Stockscreener 앱 받기
2.76
0.00%
0.00
전일 마감가:
$2.76
열려 있는:
$2.85
하루 거래량:
2,280
Relative Volume:
0.16
시가총액:
$3.77M
수익:
$5.67M
순이익/손실:
$-13.98M
주가수익비율:
-0.1284
EPS:
-21.5
순현금흐름:
$-15.30M
1주 성능:
+3.95%
1개월 성능:
-41.28%
6개월 성능:
-5.64%
1년 성능:
-8.31%
1일 변동 폭
$2.76
$2.85
1주일 범위
$2.57
$2.85
52주 변동 폭
$1.8512
$5.34
아카디아 바이오사이언시스 Stock (RKDA) Company Profile
명칭
Arcadia Biosciences Inc
전화
530-756-7077
주소
202 COUSTEAU PLACE, DAVIS, CA
RKDA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
2.76 | 3.77M | 5.67M | -13.98M | -15.30M | -21.50 |
|
KHC
Kraft Heinz Co
|
31.93 | 38.98B | 26.13B | 1.37B | 3.00B | 2.42 |
|
GIS
General Mills Inc
|
66.23 | 36.93B | 19.80B | 2.40B | 2.78B | 4.10 |
|
K
Kellanova Co
|
81.15 | 27.75B | 12.80B | 1.01B | 927.00M | 2.50 |
|
MKC
Mccormick Co Inc
|
77.79 | 21.04B | 6.68B | 792.60M | 774.40M | 2.40 |
|
HRL
Hormel Foods Corp
|
31.92 | 17.51B | 11.98B | 780.78M | 902.87M | 1.61 |
아카디아 바이오사이언시스 Stock (RKDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-17 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-12 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2015-06-09 | 개시 | Credit Suisse | Outperform |
| 2015-06-09 | 개시 | Piper Jaffray | Overweight |
아카디아 바이오사이언시스 주식(RKDA)의 최신 뉴스
Arcadia Biosciences (STU:17D) Owner Earnings per Share (TTM) : -5.72 (As of Sep. 2024) - GuruFocus.com
‘GoodWheat’: Arcadia Biosciences launches limited release of reduced-gluten non-GMO wheat flour - FoodNavigator-USA.com
Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y - MSN
Arcadia Biosciences (FRA:17D) 3-Year FCF Growth Rate : 54.40% (As of Jun. 2024) - GuruFocus.com
Arcadia Biosciences (FRA:17D) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
Arcadia Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q3 2024 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences: Q3 Earnings Snapshot - Darien Times
Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Challenges - GuruFocus.com
Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Arcadia Biosciences Reports Strong Q3 2024 Growth - TipRanks
Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights - Quantisnow
Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
CFO takes over as CEO at Arcadia - Food Business News
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call - Quantisnow
Zacks Industry Outlook Highlights Bunge, West Fraser Timber, Hydrofarm and Arcadia Biosciences - Yahoo Finance
Arcadia Biosciences stock hits 52-week high at $4 - Investing.com India
Arcadia Biosciences stock hits 52-week high at $4 By Investing.com - Investing.com South Africa
Resistant Starch Market: 2024 Global Future Scope, - openPR
ARDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Simplify Asset Management Inc. Buys 248,000 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
ARCA biopharma (NASDAQ:ABIO) Earns Sell Rating from Analysts at StockNews.com - Defense World
Ares Capital Co. (NASDAQ:ARCC) Receives $21.71 Consensus PT from Brokerages - Defense World
Seven Eight Capital LP Trims Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
WINTON GROUP Ltd Sells 14,344 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - Defense World
Arcellx Sees Unusually Large Options Volume (NASDAQ:ACLX) - Defense World
Ardelyx (NASDAQ:ARDX) Trading Down 3.6% - Defense World
Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 3.5% - Defense World
Arko gains for a second day after report it's mulling sale of convenience stores - Seeking Alpha
Metric Deep Dive: Understanding Ares Capital Corp (ARCC) Through its Ratios - The Dwinnex
Aclaris Therapeutics (NASDAQ:ACRS) Receives “Neutral” Rating from HC Wainwright - Defense World
Arcus Biosciences, Inc. (NYSE:RCUS) Receives Average Recommendation of “Buy” from Brokerages - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acadia Healthcare Company, Inc.ACHC - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming DeadlinesARDX - PR Newswire
Aclaris Therapeutics (NASDAQ:ACRS) Receives "Neutral" Rating from HC Wainwright - MarketBeat
First Week of January 2027 Options Trading For Ares Capital (ARCC) - Nasdaq
Ares Capital Co. (NASDAQ:ARCC) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Ares Capital (ARCC) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Arcturus Therapeutics Holdings Inc (ARCT) expanding its growth trajectory ahead - SETE News
R1.3bn start to ARC’s financial year - Moneyweb
ARC Investments firms over 4% on strong portfolio growth - Moneyweb
Here's Why Investors Should Invest in Arcturus Stock Now - Zacks Investment Research
Recent Insider Activity Suggests Potential Gains for Arcutis Biotherapeutics Inc (ARQT) - Knox Daily
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - Stockhouse Publishing
Arcturus Therapeutics Holdings Inc [ARCT] Insider Activity: An Update for Investors - Knox Daily
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Consensus Rating of “Buy” by Brokerages - Defense World
ACHC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Acadia Healthcare Company, Inc. and Encourages Investors to Contact the Firm! - PR Newswire
Arcadia Biosciences ~ SONOVA 400 - Natural Products Insider
Amendment: Arcadia Biosciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits - Quantisnow
Wheat no longer in Arcadia’s future - Food Business News
아카디아 바이오사이언시스 (RKDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아카디아 바이오사이언시스 주식 (RKDA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schaefer Thomas J. | Chief Executive Officer |
Aug 01 '24 |
Buy |
2.06 |
700 |
1,442 |
2,119 |
| Schaefer Thomas J. | Chief Financial Officer |
Feb 01 '24 |
Buy |
2.06 |
700 |
1,442 |
1,419 |
0.16%
0.95%
자본화:
|
볼륨(24시간):